UPDATE: Morgan Stanley Reiterates On Covidien plc On Expected Earnings Growth Acceleration

By: via Benzinga
In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating on Covidien plc (NYSE: COV), and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.